Beijing Tong Ren Tang Chinese Medicine Company Limited(BJTRF)
USD --+0.00%
Reward42Moderate
Risk29Low
📊75%Data
Strong 26% profit margin · 57.1% dividend yield · Revenue down 21% YoY
BJTRF
+0.0 · +0.00%
USD · PINK
Beijing Tong Ren Tang Chinese Medicine Company Limited | Healthcare
Dividend King
Market Cap:542.78M
ℹ️
Reward Rating
42
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
29
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on BJTRF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Beijing Tong Ren Tang Chinese Medicine Company Limited?

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

BJTRF · Verdict

Moderate reward · low risk

BJTRF stands out on balance sheet and volatility, but watch the growth signal.

Based on 88% data coverage

BJTRF · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet92/100

    Interest covered 83.7×

  • Volatility80/100

    Top decile vs peers

Watchouts 1

  • Growth25/100

    Rev -4.3% CAGR · earnings -14.9%

Model-based scoring. For information only — not financial advice.

What is Beijing Tong Ren Tang Chinese Medicine Company Limited?

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 542.78M, and a P/E ratio of 8.1x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue growth is subdued, limiting near-term earnings expansion.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (42)

The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap542.78M
P/E Ratio8.105
Dividend Yield57.06%
52 Week High0.6484
52 Week Low0.5962
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding837M
No. of Employees780
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta0.444
CurrencyUSD